Utility of Trypsinogen -2 in Early Detection and Follow Up of Post-pancreatectomy Acute Pancreatitis (PPAP)

Part of paid clinical trials in Indianapolis, Indiana.

Sponsor
Indiana University
Study ID
NCT06903676
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • TRP-2 Urine Dipstick — DEVICE
    Urine dipstick testing for Trypsinogen-2

Study Details

The goal of this study is to learn if urine trypsinogen can be used to diagnose post-pancreatectomy acute pancreatitis in patients undergoing pancreatectomy. Participants will have their urine measured by dipsticks during and after their surgery.

Key Dates

Start date
Aug 5, 2025
Status verified
Mar 2026
Primary completion
Apr 30, 2026
Completion
Apr 30, 2026

Study Design

Enrollment
50 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC

Arms

  • Experimental: Pancreatectomy Patients
    Patients who underwent pancreatectomy and are having their urine dipstick tested for Trypsinogen-2

Primary Outcome Measure

Detection of PPAP by Urine Trypsinogen 2 [ Time Frame: Day of surgery and post-operative days 1, 2 and 3 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Indiana University Health University HospitalIndianapolisIndiana46202
Nicholas Zyromski, MD
[email protected]
317-944-5012

Find similar trials in Indianapolis, IN

By research site
Indiana University Health University Hospital· Indianapolis, IN

Related Studies